Scott W. Biggins
Associate Professor
Chief, Hepatology
Director, UW Medicine Liver Care Line
Co-Director, Liver Transplant Program
Division of Gastroenterology

Faculty Information


Scott Biggins, M.D., M.S., is a board certified physician, UW Medicine’s chief of Hepatology, director of the UW Liver Care Line and co-director of the UW's Liver Transplant Program.

Dr. Biggins is a nationally recognized clinician, researcher and leader in the field of Hepatology. He believes that medical care should focus on health rather disease and that the physician-patient relationship is a partnership toward optimizing health and quality of life.  He is recognized for his outstanding mentoring and teaching of the next generation of hepatologists and is active in the development of national policies related to liver transplantation. 

Dr. Biggins earned his M.D. at USC and his M.S. at UC San Francisco. He is triple board certified in Hepatology, Gastroenterology and Internal Medicine. He has been awarded research funding from the American Liver Foundation, National Institutes of Health and the Agency for Healthcare Research and Quality.

Board Certifications:

  • Transplant Hepatology, 2006, American Board of Internal Medicine
  • Gastroenterology, 2005American Board of Internal Medicine
  • Internal Medicine, 2002, American Board of Internal Medicine
Education & Training: 
Master in Clinical Research
University of California, San Francisco
Fellowship in Gastroenterology/Hepatology
University of California, San Francisco
Residency in Internal Medicine
Oregon Health & Science University
Internship in Internal Medicine
Oregon Health & Science University
Medical Education
University of Southern California - Keck School of Medicine
Research & Clinical Interests
Clinical Interests: 
  • Gastroenterology (Digestive)
  • Liver Transplant and Evaluation
  • Hepatology (Liver)

Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retranspantation for hepatic allograft failure: Prognostic modeling and ethical considerations. Liver Transpl. April/2002:8(4):313-22. [PMID 11965573] [review]

Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology, Jan/2005;41(1):32-9. [PMID 15690479] [original work]

Biggins SW, Terrault NA. Treatment of recurrent hepatitis C after liver transplantation. Clin Liver Dis, Aug/2005;9(3):505-23. [PMID 16023980] [review]

Biggins SW, Terrault NA. Management of recurrent hepatitis C in liver transplant recipients. Infect Dis Clin North Am, Mar/2006;20(1):155-74. [PMID 16527654] [review]

. **Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-Based Incorporation of Serum Sodium Concentration Into MELD. Gastroenterology, Jun/2006;130(6):1652-1660. [PMID 16697729] [original work]

Biggins SW, Bambha K. MELD-Based Liver Allocation: Who Is Underserved? Semin Liver Dis, Aug/2006;26(3):211-20. [PMID16850370] [review]

Biggins SW, Colquhoun S, Gish RG, Runyon BA. Model for end-stage liver disease (MELD) exception for ascites. Liver Transpl, Dec/2006;12 Suppl 3:S88-90. [PMID17123288] [review]

. McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR, Vargas H, Donovan J, Trotter J, Faust T. Retransplantation for hepatitis C: Results of a U.S. multicenter retransplant study. Liver Transpl, Aug/2007;13(9):1246-1253. [PMID 17763405] [original work]

Bambha KM, Biggins SW. Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions. Curr Opin Organ Transplant, Jun/2008;13(3):227-33. [PMID 18685308] [review]

**Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med, Sep/2008;359(10):1018-26. [PMID 18768945] [original work]

Biggins SW, Bambha K, Terrault N, Inadomi J, Roberts JP, Bass N. Transplant tourism to China: the impact on domestic patient-care decisions. Clin Transplant, Jan/2009; 23(6):831-8. [PMID 19191815]

Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, Merion RM. Survival benefit-based deceased-donor liver allocation. Am J Transplant, Apr/2009;9(4 Pt 2):970-81. [PMID 19341419] [original work]

Yun BC, Kim WR, Benson JT, Biggins SW, Therneau TM, Kremers WK, Rosen CB, Klintmalm GB. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology, May/2009;49(5):1610-5. [PMID 19402063] [original work]

Guy J, Somsouk M, Shiboski S, Kerlan R, Inadomi JM, Biggins SW. New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt. Clin Gastroenterol Hepatol, Nov/2009;7(11):1236-40. [PMID 19560557] [original work]

Somsouk M, Yee HF, Biggins SW. Understanding liver health using the National Center for Health Statistics. Dig Dis Sci, Nov/2009;54(11):2325-9. [PMID 19424799] [review]

Somsouk M, Guy J, Biggins SW, Vittinghoff E, Kohn MA, Inadomi JM. Ascites improves upon plus serum sodium model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease. Aliment Pharmacol Ther, Oct/2009;30(7):741-8. [PMID 19604177] [original work]

Lai JC, Terrault NA, Vittinghoff E, Biggins SW. Height contributes to the gender difference in waitlist mortality under the MELD-based liver allocation system. Am J Transplant. Dec/2010;10(12):2658-64. [PMID 21087414] [original work]

Buxbaum J, Biggins SW, Bagatelos K, Ostroff J. Predictors of endoscopic treatment of outcomes in the management of post liver transplant biliary problems at a high volume academic center. Gastrointest Endosc. 2011 Jan/2011;73(1):37-44. [PMID 21074761] [original work]

Somsouk M, Kornfield R, Vittinghoff E, Inadomi J, Biggins SW. Moderate ascites identifies patients with low MELD awaiting liver transplantation with high mortality risk. Liver Transpl. Feb/2011;17(2):129-36. [PMID21280185] [original work]

Benson AB, Burton J, Austin G, Biggins SW, Zimmerman M, Kam I, Mandell S, Silliman C, Rosen HR, Moss M. Differential effect of plasma and red blood cell transfusion on acute lung injury and infection risk following liver transplantation. Liver Transpl. Feb/2011;17(2):149-58. [PMID 21280188] [original work]

Zheng P, Kornfield R, Olmo C, Guy J, Inadomi J, Biggins SW. Reduced effectiveness of standard recruitment for deceased ordan donor registration: The need for population-specific recruitment materials. Dig Dis Sci. May/2011;56(5):1535-41. [PMID 21221784] [original work]

Buxbaum JL, Biggins SW, Bagatelos KC, Inadomi JM, Ostroff JW. Inoperable pancreatic cancer patients who have prolonged survival exhibit an increased risk of cholangitis. J. Pancreas. July/2011;12(4):377-83. [PMID 21737900] [original work]

Volk ML, Biggins SW, Huang MA, Argo CK, Fontana RJ, Anspach RR. Decision making in liver transplant selection committees. Ann Internal Med. Sept/2011;155: 503-8. [PMID 22007044] [original work]

Brandman D, Biggins SW, Hameed B, Roberts JR, Terrault NA. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver International Jan/2012;32(1):158-64. [PMID22098119] [original work]

**Biggins SW. Futility and Rationing in Liver Retransplantation: When and how can we say no? J. Hepatology. June/2012;56(6):1404-11. [PMID 22314427] [review]

Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS. Simultaneous Liver-Kidney Summit: Current State and Future Directions. Am J Transplant Nov/2012; 12(11): 2901- 2908. [PMID 22822723] [review]

Smith JM*, Biggins SW*, Haselby DG*, Kim WR, Wedd J, Lamb K, Thompson B, Segev DL, Gustafson S, Kandaswamy R, Stock PG, Matas AJ, Samana CJ, Sleeman EF, Stewart D, Harper A, Edwards E, Snyder JJ, Kasiske BL, Israni AK. Kidney, Pancreas and Liver Allocation and Distribution in the United States. Am J Transplant. Dec/2012; 12(12): 3191-212. *Each author equally contributed as first author. [PMID 23157207] [review]

**Biggins SW, Bambha KM, Terrault NA, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP. Projected future increase in aging HCV-infected liver transplant candidates: A potential effect of HCC. Liver Transplantation. Dec/2012;18(12):1471-8. [PMID 23008049] [original work]

Biggins SW, Trotter J, Gralla JU, Burton J, Bambha KM, Dodge J, Brocato M, Cheng L, McQueen M, Forman L, Chang M, Kam I, Everson G, Spritz RA, Klintmalm G, Rosen HR. Differential effects of donor Scott W. Biggins 2/7/2020 and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. J. Hepatol. May/2013;58(5):969-76. [PMID 23333445] [original work]

Wedd JP, Harper AM, Biggins SW. MELD score, allocation, and distribution in the United States. Clinical Liver Disease, Aug/2013 2:148–151. [review]

Regalia K, Zheng P, Sillau S, Aggarwal A, Bellevue O, Fix OK, Prinz J, Dunn S, Biggins SW. Demographic factors affect willingness to register as an organ donor more than a personal relationship with a transplant candidate. Dig Dis Sci. July/2014 ;59(7):1386-91.[PMID 24519521] [original work]

Stotts MJ, Hung KW, Benson A, Biggins SW. Rate and predictors of successful cardiopulmonary resuscitation in end-stage liver disease. Dig Dis Sci. Aug/2014 ; 59(8): 1983-6 [PMID 24599771] [original work]

Leise MD, Yun BC, Larson JJ, Benson JT, Dongyang J, Therneau TM, Rosen CB, Heimbach JK, Biggins SW, Kim WR. The effect of pretransplant serum sodium concentration on outcome following liver transplantation. Liver Transplantation. Jun/2014; 20(6):687-97.[PMID 24616214] [original work]

Bajaj J, O’Leary JG, Reddy KR, Wong F, Biggins SW, Patton HM, Fallon MB, Garcia-Tsao G, Maliakkal B, Malik R, Subramanian RM, Thacker L, Kamath PS. Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures. Hepatology jun/2014; 60(1): 250-6. [PMID 24677131] [original work]

Wedd J, Bambha KM, Stotts M, Laskey H, Colmernero J, Gralla, J, Biggins SW. Stage of cirrhosis predicts risk of liver related death in low MELD pateints with cirrhosis awaiting liver transplant. Liver Transplantation Oct/2014; 10: 1193-201. [PMID 24916539] [original work]

**Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Baron AE, Inadomi J, Terrault NA, Rosen HR. Survival benefit of repeat liver transplantation in the US: A serial MELD analysis by hepatitis C status and donor risk index. Am J Transpl.Nov/2014; 14(11):2588-94. [PMID 25243648] [original work]

O’Leary JG, Reddy KR, Wong F, Kamath PS, Patton HM, Biggins SW, Fallon MB, Garcia-Tso G, Subramanian RM, Malik R, Thacker LR, Bajaj JS. Long-term use of antibiotics and proton-pump inhibitors predict development of infection in patients with cirrhosis. Clin Gastroenterol Hepatol. Apr 2015; 13(4):753-9. [PMID 25130937] [original work]

Dirchwolf M, Ruf AE, Biggins SW, Bisigniano L, Krogh DH, Vilamil FG. Donor selection for liver transplantation in Argentina: Are current standards too rigorous? Transpl. Int. Feb/2014; 28(2):206- 13.[PMID 25406336] [original work]

Green M, Covington S, Taranto S, Wolfe C, Bell W, Biggins SW, Conti D, DeStefanto GD, Dominguez E, Ennis D, Gross T, Klassen-Fisher M, Kotton C, LaPointe-Rudow D, Law Y, Ludrosky K, Menegus M, Morris MI, Nalesnik MA, Pavlakis M, Prutt T, Sifri C, Kaul D. Donor-driven transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. Feb/2015; 99(2): 282-7. [PMID 25594557] [original work]

Mandell MS, Seres T, Lindenfeld J, Biggins SW, Chascsa D, Ahlgren B, Wachs M, Bambha KM. Risk factors associated with acute heart failure during liver transplant surgery: A case control study. Transplantation Apr/2015; 99(4):873-8. [PMID 25208319] [original work]

Reddy KR, O’Learly JG, Kamath PS, Fallon MB, Biggins SW, Wong F, Patton HM, Garcia-Tsao G, Subramanian RM, Thacker LR, Bajaj JS. High risk of delisting or death in liver transplant candidates following infections: Results from NACSELD. Liver Transp. Jul/2015; 21(7):881-8. [PMID 25845966] [original work]

Dirchwolf M, Dodge JL, Gralla J, Bambha KM, NydamT, Hung KM, Rosen HR, Terrault NA, Biggins SW. The corrected donor age for hepatitis C virus-infected liver transplant recipients. Liver Transplantation Aug/2015; 21(8):1022-30. [PMID 26074140] [original work]

Bambha KM, Dodge JL, Gralla J, Sprague D, Biggins SW. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by MELD. Liver Transplantation Oct/2015;21(10):1286-94. [PMID 26097202] [original work]

Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics. Liver Transplantation. Nov/2015;21(11):1365-73.[PMID 25865434] [original work]

Nordstrom EM, Biggins SW, Gralla J, Rosen HR, Everson GT, Burton JR. Consensus Interferon for Recurrent Hepatitis C Infection in Nonresponders to Peginterferon and Ribavirin After Liver Transplant. Exp Clin Transplant Dec/2015; 13(6):543-9. [PMID 26643674] [original work]

Wedd, JP, Nordstrom E, Nydam T, Durham J, Zimmerman M, Johnson T, Purcell WT, Biggins SW. Hepatocellular Carcinoma in Patients Listed for Liver Transplantation: Current and future allocation policy and management strategies for the individual patient. Liver Transpl Dec/2015;21(12):1543-52. [PMID 26178066] [review]

Rosen HR, Biggins SW, Kinki T, Gralla J, Hillman H, Hirashima M, Schilsky M, Lee WM. Association between plasma level of galectin-9 and survival of patients with drug-induced acute liver failure. Clin Gastroenterol Hepatol April/2016; 14(4):606-612.[PMID 2699927] [original work]

Kalra A, Wedd JP, Biggins SW. Changing prioritization for transplantation: MELD-Na, hepatocellular carcinoma exceptions and more. Curr Opin Organ Transplant. Apr/2016;21(2):120-6 2016 [PMID 26825358] [review]

Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Biggins SW, Thuluvath PJ, Fallon MB, Subramanian RM, Vargas H, Thacker LR, O'Leary JG; NACSELD. The three month readmission rate remains unacceptably high in a large north American cohort of cirrhotic patients. Hepatology July/2016; 64(2)120-6.[PMID 26690389] [original work]

Laskey HL, Schomaker N, Hung KW, Asrani SK, Jennings L, Nydam, TL, Gralla J, Wiseman A, Rosen HR, Biggins SW. Predicting renal recovery after liver transplant with severe pretransplant subacute kidney injury: The impact of warm ischemic time. Liver Transpl Aug/2016; 22(8):1085-91.[PMID 27302834] [original work]

Kalra A, Wedd JP, Bambha KM, Gralla J, Golden-Mason L, Collins C, Rosen HR, Biggins SW. Neutrophil-to-Lymphocyte Ratio Correlates with Proinflammatory Neutrophils and Predicts Death in Low MELD Cirrhotic Patients. Liver Transpl, 2017 Feb;23(2):155-165. [PMID 28006875] [original work]

O’Leary JG, Wong F, Reddy KR, Garcia-Tsao G, Kamath PS, Biggins SW, Fallon MB, Subramania RM, Maliakkal B, Thacker L, Bajaj JS. Gender-specific differences in baseline, peak, and delta serum creatinine: The NACSELD experience. Dig Dis Sci. 2017 Mar;62(3):768-776 [PMID 28025746] [original work]

Tandon P, Reddy KR, O’Leary JG, Garcia-Tsao G, Abraldes JG, Wong F, Biggins SW, Maliakkal B, Fallon MB, Subramanian RM, Thuluvath P, Kamath PS, Thacker LR, Bajaj JS. A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology 2017. Jan 2017; 65(1)217-224. [PMID 27775842] [original work]

Wong F, O'Leary JG, Reddy KR, Garcia-Tsao G, Fallon MB, Biggins SW, Subramanian RM, Thuluvath PJ, Kamath PS, Patton H, Maliakkal B, Tandon P, Vargas H, Thacker L, Bajaj JS. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes. Am J Gastroenterol. 2017 Jul;112(7):1103-1110. [PMID 28440305] [original work]

Bajaj JS, Rajender Reddy K, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Fallon M, Maliakkal B, Lai J, Vargas HE, Subramanian RM, Thuluvath P, Thacker LR, O'Leary JG. Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort. Am J Gastroenterol. 2017 [epub ahead of print] [PMID 29257141] [original work]

O'Leary JG, Reddy KR, Garcia-Tsao G, Biggins SW, Wong F, Fallon MB, Subramanian RM, Kamath PS, Thuluvath P, Vargas HE, Maliakkal B, Tandon P, Lai J, Thacker LR, Bajaj JS. NACSELD Acute-onChronic Liver Failure (NACSELD-ACLF) Score Predicts 30-Day Survival in Hospitalized Patients with Cirrhosis. Hepatology. 2018 Jun;67(6):2367-2374. [PMID 29315693] [original work]

Kalra A, Biggins SW. New paradigms of organ allocation and distribution in liver transplantation. Curr Opin Gastroenterol. 2018 May;34(3):123-131. [PMID 29465430] [invited review]

Dirchwolf M, Marciano S, Giunta DH, Posadas-Martínez ML, Biggins SW, Ruf AE. Trends in liver transplantation for hepatitis C in a country with reduced access to direct-acting antiviral agents. Clin Transplant. 2018 Feb 27. [epub ahead of print] [PMID 29485711] [original work]

Delzer LM, Golightly LK, Kiser TH, Biggins SW, Lewis VJ, Kim II. Calcineurin Inhibitor and Nonsteroidal Anti-inflammatory Drug Interaction: Implications of Changes in Renal Function Associated With Scott W. Biggins 2/7/2020 Concurrent Use. J Clin Pharmacol. J Clin Pharmacol. 2018 Nov;58(11):1443-1451 [PMID 29799625] [original work]

Bajaj JS, Tandon P, O'Leary JG, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai JC, Fallon M, Thuluvath P, Vargas HE, Subramanian RM, Thacker LR, Reddy KR. The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis. Am J Gastroenterol. 2018 Sep;113(9):1339. [PMID 29880972] [original work]

Sibulesky L, Biggins SW, Pichler R. Protecting kidneys in liver transplant patients: A pathway to preventive interventions. World J Hepatol. 2018 Sep 27;10(9):637-638/ [PMID 30310542] [Review]

Shingina A, DeWitt PE, Dodge JL, Biggins SW, Gralla J, Sprague D, Bambha K. Future Trends in Demand for Liver Transplant: Birth-Cohort Effects among Patients with NASH and HCC. Transplantation. 2019 Jan;103(1):140-148. [PMID 30451739] [original work]

Vutien P, Dodge J, Bambha K, Nordstrom E, Gralla J, Campbell K, Levek C, Nydam T, Fix O, Ioannou G, Biggins SW. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence after Liver Transplantation: The RH-IML Classification. Liver Transpl, 2019 Apr;25(4):559-570. [PMID 30706653] [original work]

Bajaj JS, Tandon P, OʼLeary JG, Wong F, Biggins SW, Garcia-Tsao G, Kamath PS, Maliakkal B, Fallon MB, Lai JC, Thuluvath PJ, Vargas HE, Subramanian RM, Thacker LR, Reddy KR. Outcomes in patients with cirrhosis on primary compared to secondary prophylaxis for spontaneous bacterial peritonitis. Am J Gastroenterol. 2019 Apr;114(4):599-606. [PMID 30694868] [original work]

O'Leary JG, Bajaj JS, Tandon P, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas HE, Thuluvath P, Subramanian R, Thacker LR, Reddy RK. Outcomes after Listing for Liver Transplant in Patients with Acute-on-Chronic Liver Failure (ACLF): The Multicenter NACSELD Experience. Liver Transpl. Liver Transpl. 2019 Apr;25(4):571-579. [PMID 30724010] [original work]

Wong F, Reddy RK, O'Leary JG, Tandon P, Biggins SW, Garcia-Tsao G, Maliakkal BJ, Lai JC, Fallon MB, Vargas HE, Subramanian R, Thuluvath PJ, Kamath PS, Thacker L, Bajaj JS. Impact of Chronic Kidney Disease on Outcomes in Cirrhosis. Liver Transpl. 2019. [epub ahead of print] [PMID 30908855] [original work]

Paine CH, Biggins SW, Pichler RH. Albumin in Cirrhosis: More Than a Colloid. Curr Treat Options Gastroenterol. 2019 Apr 9. [Epub ahead of print] [PMID 30968341] [Review]

Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort. Aliment Pharmacol Ther. 2019 Apr 29. [epub ahead of print] [PMID 31032966] [original work]

Kling CE, Perkins JD, Biggins SW, Johnson CK, Limaye AP, Sibulesky L. Listing practices and graft utilization of hepatitis C-positive deceased donors in liver and kidney transplant. Surgery. 2019 May 6. [epub ahead of print] [PMID 31072671] [original work]

Bajaj JS, OʼLeary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Biggins SW, Lai JC, Vargas HE, Maliakkal B, Fallon MB, Thuluvath PJ, Subramanian RM, Thacker LR, Reddy KR. Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis. Am J Gastroenterol. 2019 Jun 6. [epub ahead of print] [PMID 31180922] [original work]

Perkins JD, Dick AA, Healey PJ, Montenovo MI, Biggins SW, Sibulesky L, Reyes JD. New Evidence Supporting Increased Use of Split Liver Transplantation. Transplantation. 2019 Jun 27. [epub ahead of print] [PMID 31335771] [original work]

Yu L, Liou IW, Biggins SW, Yeh M, Jalikis F, Chan LN, Burkhead J. Copper Deficiency in Liver Diseases: A Case Series and Pathophysiological Considerations. Hepatol Commun. 2019 Jun 26;3(8):1159-1165. [PMID 31388635] [original work]

Bambha K, Shingina A, Dodge JL, O'Connor K, Dunn S, Prinz J, Pabst M, Nilles K, Sibulesky L, Biggins SW. Solid organ donation after death in the United States: Data-driven messaging to encourage potential donors. Am J Transplant. 2020 Jan 9. [Epub ahead of print] [PMID 31917506] [original work]

O'Leary JG, Tandon P, Reddy KR, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas HE, Thuluvath P, Subramanian R, Thacker LR, Bajaj JS. Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience. Dig Dis Sci. 2020 [Epub ahead of print] [PMID: 32146602] [original work]

Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Insurance Status but Not Race/Ethnicity Are Associated With Outcomes in a Large Hospitalized Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020 [Epub ahead of print] [PMID: 32389884] [original work]

Bajaj JS, Garcia-Tsao G, Biggins SW, Kamath PS, Wong F, McGeorge S, Shaw J, Pearson M, Chew M, Fagan A, de la Rosa Rodriguez R, Worthington J, Olofson A, Weir V, Trisolini C, Dwyer S, Reddy KR. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut 2020. [Epub ahead of print] [PMID: 32660964] [original work]

Wong F, Reddy KR, Tandon P, O'Leary JG, Garcia-Tsao G, Vargas HE, Lai JC, Biggins SW, Maliakkal B, Fallon M, Subramanian R, Thuluvath P, Kamath PS, Thacker L, Bajaj JS. Progression of Stage 2 and 3 Acute Kidney Injury in Patients with Decompensated Cirrhosis and Ascites. Clin Gastroenterol Hepatol. 2020 Aug. [Epub ahead of print] [PMID: 32798707] [original work]

Kim NJ, Su F, Biggins SW. CON: Noninvasive Modalities Are Preferred to Screen for the Diagnosis of Esophageal and Gastric Varices When the Diagnosis of Cirrhosis Is Made. Clin Liver Dis (Hoboken) 2020 Sep 4;16(2):48-52. [PMID: 32922749] [Review]

Hu C, Anjur V, Saboo K, Reddy KR, OʼLeary J, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Lai JC, Biggins SW, Fallon MB, Thuluvath P, Subramanian RM, Maliakkal B, Vargas H, Thacker LR, Iyer RK, Bajaj JS. Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis. Am J Gastroenterol 2020 Oct. [Epub ahead of print] [PMID: 33038139] [original work]

O'Leary JG, Rajender Reddy K, Tandon P, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai JC, Fallon M, Vargas HE, Thuluvath P, Subramanian R, Thacker LR, Bajaj JS. Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax. Dig Dis Sci. 2020 Nov 13. [Epub ahead of print] [PMID: 33185787] [original work]

Kriss M, Biggins SW. Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving process. Curr Opin Organ Transplant. [Epub ahead of print] [PMID:33278150] [Review]

Bajaj JS, Garcia-Tsao G. Wong F, Biggins SW, Kamath PS, McGeorge S., Chew M, Pearson, M, Shaw J, Kalluri A, Olofson A, Fagan A, Moini, M, de la Rosa Rodriguez R, Reddy KR. Cirrhosis is associated with high mortality and readmissions over 90 days regardless of covid-19: a multi-center cohort. Liver Transpl 2021. [Epub ahead of print] [PMID: 33427401] [original work]